Design and characterisation of long-r3-insulin-like growth factor-I muteins which show resistance to pepsin digestion

Growth Factors

Volumn 13, Issue 3-4, 1996, Pages 261-272

  Bryant, K J ^a   Read, L C ^b   Forsberg, G ^a   Wallace, J C ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CHILD HEALTH RESEARCH INSTITUTE   (Australia)

Author keywords

Biological activity; IGF I muteins; Kinetics of degradation; Pepsin resistance; Receptor binding; Site directed mutagenesis

Indexed keywords

MUTANT PROTEIN; PEPSIN A; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STABILITY; POINT MUTATION; PRIORITY JOURNAL;

EID: 0029862348     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199609003227     Document Type: Article

References (28)

1. Bayne, M. L., Applebaum, J., Chicchi, G.G., Hayes, N. S., Green, B. G. and Cascieri, M. A. (1988) Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor. J. Biol. Chem. 263, 6233-6239.
2. Bayne, M. L., Applebaum, J., Chicchi, G. G., Miller, R. E. and Cascieri, M. A. (1990) The roles of tyrosines 24, 31 and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J. Biol. Chem. 265, 15648-15652.
3. Bordo, D. and Argos, P. (1991) Suggestions for "safe" residue substitutions in site-directed mutagenesis. J. Mol. Biol. 217, 721-729.
4. Cascieri, M. A., Chicchi, G. G., Applebaum, J., Green, B. G., Hayes, N. S. and Bayne, M. L. (1989) Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors. J. Biol. Chem. 264, 2199-2202.
5. Cascieri, M. A., Chicchi, G. G., Applebaum, J., Hayes, N. S., Green B. G. & Bayne, M. L. (1988) Biochemistry 27, 3229-3233.
6. Cascieri, M. A., Chicchi, G. G. and Bayne, M. L. (1991) Characterisation of the biological activity of IGF I analogs with reduced affinity for the IGF receptors and binding proteins. In Molecular Biology and Physiology of Insulin and Insulin-like Growth Factors (Raizada, M. K. and LeRoith, D., ed.), pp. 23-30, Plenum Press, New York.
7. Buck, M. A., Olah, T. A., Weitzmann, C. J. and Cooperman, B. S. (1989) Protein estimation by the product of integrated peak area and flow rate. Anal. Biochem. 182, 295-299.
8. Cooke, R. M., Harvey, T. S. and Campbell, I. D. (1991) Solution structure of human insulin-like growth factor I: A nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry 30, 5484-5491.
9. Daughaday, W. H., Mariz, I. K. and Trivedi, B. (1981) J. Clin. Endocrinol. Metab. 53, 282-288.
10. Dixon, M. and Webb, E. C. (1964) Enzymes (2nd ed), Longmans Green & Co Ltd, London.
11. Florence, A. T. and Jani, P. U. (1994) Novel oral drug formulations. Their potential in modulating adverse effects. Drug Safety 10, 233-266.
12. Forsberg, G., Palm, G., Ekebacke, A., Josephson, S. and Hartmanis, M. (1990) Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli. Biochem. J. 271, 357-363.
13. Francis, G. L., Read, L. C., Ballard, F. J., Bagley, C. J., Upton, F. M., Gravestock, P. M. and Wallace, J. C. (1986) Purification and partial sequence analysis of insulin-like growth factor-I from bovine colostrum. Biochem. J. 8, 207-213.
14. Francis, G. L., Ross, M., Ballard, F. J., Milner, S. J., Senn, C. McNeil, K. A., Wallace, J. C., King, R. and Wells, J. R. E. (1992) Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological activity. J. Mol. Endocrinol. 8, 213-223.
15. Hunkapiller, M. W., Hewick, R. M. Dreyer, W. J. and Hood, L. E. (1983) High sensitivity sequencing with a gas phase sequenator. Methods in Enzymol. 91, 399-413.
16. Jones, J. I. and Clemmons, D. R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16, 3-34.
17. 3, following their expression in Escherichia coli as fusion proteins. J. Mol. Endocrinol. 8, 29-41.
18. McCusker, R. H., Cacacho-Hubner, C. and Clemmons, D. R. (1989) Identification of the types of insulin-like growth factor binding proteins that are secreted by muscle cells in vitro. J. Biol. Chem. 264, 7795-7800.
19. Oh, Y., Müller, H. L. Lee, D.-Y, Fielder, P. J. and Rosenfeld, R. G. (1993) Characterization of the affinities of insulin-like growth factor (IGF) binding proteins 1-4 for IGF-I, IGF-II, IGF-I/ insulin hybrid and IGF-I analogs. Endocrinology 132, 1337-1344.
20. Peters, M. A., Lau, E. P., Snitman, D. L., Van Wyk, J. J., Underwood, L. E., Russell, W. E. and Svoboda, M. E. (1985) Expression of a biologically active analogue of somatomedin-C/ insulin-like growth factor I. Gene 35, 83-89.
21. Ranade, V. V. (1991) Drug Delivery Systems 5A. Oral drug delivery. J. Clin. Pharmacol. 31, 2-16.
22. Read, L. C., Tomas, F. M., Howarth, G. S., Martin, A. A., Edson, K. J., Gillespie, C. M., Owens, P. C. and Ballard, F. J. (1992) Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J. Endocrinol. 133, 421-432.
23. Ross, M., Francis, G. L., Szabo, L., Wallace, J. C. and Ballard, F. J. (1989) Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-II, but not des(1-3)IGF-I. Biochem. J. 258, 267-272.
24. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning, A Laboratory Manual (edited by Nolan, C., Ford, N. and Ferguson, M.), Cold Spring Harbour Press, New York.
25. 1H-NMR and distance geometry. Int. J. Peptide Protein Res. 41, 433-440.
26. Steeb, C.-B., Trahair, J. F., Tomas, F. M. and Read, L. C. (1994) Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am. J. Physiol. 266, G1090-G1098.
27. Upton, Z., Francis, G. L., Ross, M., Wallace, J. C. and Ballard, F. J. (1992) Production and characterization of recombinant chicken insulin-like growth factor-I from Escherichia coli. J. Mol. Endocrinol. 9, 83-92.
28. Xian, C. J., Shoubridge, C. A. and Read, L. C. (1995) Degradation of IGF-I in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein. J. Endocrinol. 146, 215-225.